ClinicalTrials.Veeva

Menu

Pelvic Alignment Level (PAL) Instrument Evaluation

Stryker logo

Stryker

Status

Terminated

Conditions

Arthroplasty, Replacement, Hip

Treatments

Device: Pelvic Alignment Level (PAL) Instrument
Device: No Pelvic Alignment Level (PAL) Instrument

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The study is conducted to evaluate the performance of the Pelvic Alignment Level (PAL) instrument in achieving desired acetabular position, desired leg length and offset after Total Hip Replacement (THR) reconstruction.

Full description

Total hip replacement (THR) has been a sucessful treatment for cases of degenerative joint diseases. However, post operative complications such as dislocations, osteolysis, component wear and migration are still a concern. It has been noted in the scientific literature that precise acetabular cup position helps reduce such post operative complications. The Pelvic Alignment Level (PAL) offers this solution by assessing pelvic motion and optimizing implant position without the need for intra-operative fluoroscopy or a large capital expenditure. The focus of this study is to evaluate the clinical outcomes (acetabular cup placement, femoral offset, and leg length) of using the PAL instrument to those without using PAL instrument during total hip replacement. This will be a prospective, post market, randomized multi-center clinical study.

Enrollment

7 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient has signed an IRB approved, evaluation specific Informed Patient Consent Form.
  • Patient is a male or non-pregnant female age 18 years or older at time of enrollment.
  • Patient clinically qualifies for total hip arthroplastic surgery, based on physical examination and medical history.
  • Patient must have a diagnosis of: osteoarthritis, traumatic arthritis, avascular necrosis, slipped capital epiphysis, pelvic fracture, failed fracture fixation or rheumatoid arthritis.

Exclusion criteria

  • Patient's anatomy precludes a cup placement of 45° inclination and 20° anteversion.
  • Patient has an active infection within the affected hip joint.
  • Patient is a prisoner.
  • Patient has plans to relocate to another geographic area before the completion of the evaluation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

7 participants in 2 patient groups

Pelvic Alignment Level (PAL)
Other group
Description:
Pelvic Alignment Level Instrument Used
Treatment:
Device: Pelvic Alignment Level (PAL) Instrument
No Pelvic Alignment Level (PAL)
Other group
Description:
No Pelvic Alignment Level Instrument Used
Treatment:
Device: No Pelvic Alignment Level (PAL) Instrument

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems